We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+13.1%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$273M
AUM Growth
+$58.5M
Cap. Flow
+$33.4M
Cap. Flow %
12.22%
Top 10 Hldgs %
31.23%
Holding
76
New
17
Increased
24
Reduced
16
Closed
9

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$8.93M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$6.98M
3
GILD icon
Gilead Sciences
GILD
+$5.99M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.38M
5
SYK icon
Stryker
SYK
+$4.12M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$6.73M
2
ZBH icon
Zimmer Biomet
ZBH
+$4.88M
3
BMY icon
Bristol-Myers Squibb
BMY
+$4.21M
4
THC icon
Tenet Healthcare
THC
+$3.98M
5
AZN icon
AstraZeneca
AZN
+$3.89M

Sector Composition

Rank Sector Weight
1 Healthcare 87.53%
2 Financials 2.5%
3 Energy 1.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
A icon
26
Agilent Technologies
A
$41.2B
$4.75M 1.74%
80,000
-10,000
-11% -$570K
TMO icon
27
Thermo Fisher Scientific
TMO
$220B
$4.36M 1.6%
25,000
– –
ABBV icon
28
AbbVie
ABBV
$435B
$4.35M 1.59%
+60,000
New +$4.03M
BHC icon
29
Bausch Health
BHC
$2.34B
$4.24M 1.55%
245,000
+45,000
+23% +$539K
SYK icon
30
Stryker
SYK
$130B
$4.16M 1.52%
+30,000
New +$4.12M
IPXL
31
DELISTED
Impax Laboratories, Inc.
IPXL
$4.03M 1.47%
250,000
+81,970
+49% +$1.21M
CAH icon
32
Cardinal Health
CAH
$55.4B
$3.9M 1.43%
50,000
+15,000
+43% +$1.13M
PRGO icon
33
Perrigo
PRGO
$1.78B
$3.4M 1.24%
45,000
+20,000
+80% +$1.43M
HRC
34
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.18M 1.17%
+40,000
New +$3.02M
SNN icon
35
Smith & Nephew
SNN
$12.6B
$3.14M 1.15%
90,000
+20,000
+29% +$677K
MDT icon
36
Medtronic
MDT
$112B
$3.11M 1.14%
+35,000
New +$2.95M
LHCG
37
DELISTED
LHC Group LLC
LHCG
$3.06M 1.12%
45,000
-4,405
-9% -$263K
HCA icon
38
HCA Healthcare
HCA
$89.5B
$3.05M 1.12%
35,000
-17,500
-33% -$1.48M
UHS icon
39
Universal Health Services
UHS
$10.5B
$3.05M 1.12%
25,000
-17,500
-41% -$2.08M
ISRG icon
40
Intuitive Surgical
ISRG
$134B
$3.04M 1.11%
29,250
+9,000
+44% +$865K
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$3.01M 1.1%
30,000
-5,200
-15% -$560K
AMED
42
DELISTED
Amedisys
AMED
$2.8M 1.03%
44,607
+10,000
+29% +$582K
ENDP
43
DELISTED
Endo International plc
ENDP
$2.79M 1.02%
+250,000
New +$2.94M
VAR
44
DELISTED
Varian Medical Systems, Inc.
VAR
$2.58M 0.94%
+25,000
New +$2.41M
GMED icon
45
Globus Medical
GMED
$11.2B
$2.56M 0.94%
+77,340
New +$2.43M
CHE icon
46
Chemed
CHE
$7.22B
$2.56M 0.94%
12,500
-2,500
-17% -$498K
ACHC icon
47
Acadia Healthcare
ACHC
$2.94B
$2.47M 0.9%
50,000
– –
CYH icon
48
Community Health Systems
CYH
$423M
$2.19M 0.8%
+220,000
New +$2.01M
TSRO
49
DELISTED
TESARO, Inc.
TSRO
$2.1M 0.77%
15,000
+4,500
+43% +$652K
ASRT
50
DELISTED
Assertio
ASRT
$1.93M 0.71%
+3,000
New +$2M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q2 2017 Portfolio in Review

As of Q2 2017, Sivik Global Healthcare held 76 positions worth $273M, up 27% from $215M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Sivik Global Healthcare deployed $33.4M of net new capital in Q2 2017, opening 17 new positions and adding to 24 existing holdings. Its largest new stake was Johnson & Johnson: 70,000 shares worth $9.26M.

By sector, the portfolio is most concentrated in Healthcare at 88% of assets, down from 88% a quarter earlier, followed by Financials and Energy.

On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $3.31M trimmed.

  • Sivik Global Healthcare's largest Q2 2017 buy was Johnson & Johnson: 70,000 shares worth $9.26M.
  • Sivik Global Healthcare added most to Alexion Pharmaceuticals in Q2 2017, an estimated $6.98M increase.
  • Sivik Global Healthcare's biggest Q2 2017 reduction was Wellcare Health Plans, Inc., cutting an estimated $3.31M.
  • Sivik Global Healthcare fully exited Eli Lilly in Q2 2017, selling an estimated $6.73M.
  • Sivik Global Healthcare's ten largest holdings make up 31% of its $273M portfolio in Q2 2017.
  • Sivik Global Healthcare opened 17 new positions and closed 9 in Q2 2017.
  • Sivik Global Healthcare's portfolio value rose 27% quarter-over-quarter to $273M.

Based on Sivik Global Healthcare's 13F filing for Q2 2017, filed 11 Aug 2017.